Search
Search Constraints
You searched for: Author/Creator Grivel, Jonathan- Grivel, Jonathan [remove] 4
- Electronic journals 2
- Periodicals 2
- 571.605 1
- 616.994 1
- 616.99406105 1
- 616.99424 1
- AE Adverse event -- BRAF B-RAF proto-oncogene serine/threonine kinase -- CI Confidence interval -- CTCAE Common Terminology Criteria for Adverse Events -- CTLA-4 Cytotoxic T-lymphocyte-associated protein 4 -- DLT Dose-limiting toxicity -- ECOG Eastern Cooperative Oncology Group -- EGFR Epidermal growth factor receptor -- GT GEFTREM -- ICI Immune checkpoint inhibitors -- ILD Interstitial lung disease -- irAE Immune-related adverse event -- IV Intravenous -- NR Not reached -- NSCLC Non-small cell lung cancer -- ORR Objective response rate -- OS Overall survival -- PD Progression disease -- PD-L1 Programmed death-ligand 1 -- PFS Progression-free survival -- Q4W Every 4 weeks -- Q12W Every 12 weeks -- RECIST Response Evaluation Criteria in Solid Tumours -- RP2D Recommended phase 2 dose -- SD Stable disease -- sCTLA-4 Soluble CTLA-4 -- TKI Tyrosine-kinase inhibitors -- TMB Tumour mutational burden -- TRAE Treatment-related adverse event -- TRM Resident memory T cells -- Vs Versus 1
- CD4-CD8 ratio -- immunotherapy -- lung neoplasms -- biomarkers -- tumor 1
- Cancer 1
- Cancer -- Immunological aspects -- Periodicals 1